FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921138927> ?p ?o ?g. }

• W2921138927 endingPage "1010" @default.
• W2921138927 startingPage "997" @default.
• W2921138927 abstract "The traditional model of evaluating treatments based primarily on primary outcome measures has stumbled in its application to rare disease. Rare disease clinical trials face the methodological challenges of small, heterogeneous patient populations and relatively few validated, disease-specific outcome measures. Incorporating qualitative research into rare disease clinical trials may help sponsors, regulators, payers, and prescribers to better understand the real-world and patient-specific impact of a potential therapy. This paper provides a methodologic overview of the use of Patient and Caregiver Perception of Change (PPC and CPC) Assessments utilizing patient and caregiver video interviews to complement the data captured by traditional endpoints in rare disease clinical trials. Incorporating qualitative patient and caregiver video interviews into clinical trials allows for the rigorous capture of patient experiences and caregiver observations. Interview guides informed by input from key stakeholders provide the opportunity to solicit structured feedback on experiences before, during, and after the clinical trial. Patients and caregivers can complete their video interviews in a study mobile application, and interview transcripts are analyzed by independent coders. Themes are summarized by the treatment group and individual patient, which adds context to the clinical outcome measures of how patients feel and function, as well as elucidates the degree of change that is meaningful to patients and caregivers. The qualitative results can be compared to the data captured in clinical trials to assess data concordance. Capturing patient experience data with sufficient rigor allows it to contribute to the body of evidence utilized in regulatory, payer, and prescriber decision-making. Adding PPC and CPC Assessments to rare disease clinical trials offers an innovative and powerful way to tap into the unique insights of patients and their families to develop a fuller picture of the patient experience in the clinical trial. Stealth BioTherapeutics Inc." @default.
• W2921138927 created "2019-03-22" @default.
• W2921138927 creator A5003764371 @default.
• W2921138927 creator A5049558757 @default.
• W2921138927 creator A5050618365 @default.
• W2921138927 creator A5071748243 @default.
• W2921138927 date "2019-03-16" @default.
• W2921138927 modified "2023-10-07" @default.
• W2921138927 title "The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview" @default.
• W2921138927 cites W1583754202 @default.
• W2921138927 cites W1981057591 @default.
• W2921138927 cites W1981986007 @default.
• W2921138927 cites W1990973473 @default.
• W2921138927 cites W2023924430 @default.
• W2921138927 cites W2040900627 @default.
• W2921138927 cites W2041646984 @default.
• W2921138927 cites W2042390728 @default.
• W2921138927 cites W2107303361 @default.
• W2921138927 cites W2131080517 @default.
• W2921138927 cites W2149965232 @default.
• W2921138927 cites W2317210650 @default.
• W2921138927 cites W2344408149 @default.
• W2921138927 cites W2519986235 @default.
• W2921138927 cites W2547287898 @default.
• W2921138927 cites W2557309514 @default.
• W2921138927 cites W2587479628 @default.
• W2921138927 cites W2597385103 @default.
• W2921138927 cites W2599749593 @default.
• W2921138927 cites W2615834213 @default.
• W2921138927 cites W2655752598 @default.
• W2921138927 cites W2735351778 @default.
• W2921138927 cites W2740425702 @default.
• W2921138927 cites W2747410013 @default.
• W2921138927 cites W2754733929 @default.
• W2921138927 cites W2766255968 @default.
• W2921138927 cites W2766356879 @default.
• W2921138927 cites W2768056166 @default.
• W2921138927 cites W2777648031 @default.
• W2921138927 cites W2795840999 @default.
• W2921138927 cites W2796430719 @default.
• W2921138927 cites W2806291669 @default.
• W2921138927 cites W2807924164 @default.
• W2921138927 cites W2886932380 @default.
• W2921138927 cites W2892063514 @default.
• W2921138927 cites W2900300149 @default.
• W2921138927 doi "https://doi.org/10.1007/s12325-019-00920-x" @default.
• W2921138927 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6824378" @default.
• W2921138927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30879250" @default.
• W2921138927 hasPublicationYear "2019" @default.
• W2921138927 type Work @default.
• W2921138927 sameAs 2921138927 @default.
• W2921138927 citedByCount "21" @default.
• W2921138927 countsByYear W29211389272019 @default.
• W2921138927 countsByYear W29211389272020 @default.
• W2921138927 countsByYear W29211389272021 @default.
• W2921138927 countsByYear W29211389272022 @default.
• W2921138927 countsByYear W29211389272023 @default.
• W2921138927 crossrefType "journal-article" @default.
• W2921138927 hasAuthorship W2921138927A5003764371 @default.
• W2921138927 hasAuthorship W2921138927A5049558757 @default.
• W2921138927 hasAuthorship W2921138927A5050618365 @default.
• W2921138927 hasAuthorship W2921138927A5071748243 @default.
• W2921138927 hasBestOaLocation W29211389271 @default.
• W2921138927 hasConcept C126322002 @default.
• W2921138927 hasConcept C142724271 @default.
• W2921138927 hasConcept C144024400 @default.
• W2921138927 hasConcept C151730666 @default.
• W2921138927 hasConcept C15744967 @default.
• W2921138927 hasConcept C159110408 @default.
• W2921138927 hasConcept C160798450 @default.
• W2921138927 hasConcept C169760540 @default.
• W2921138927 hasConcept C1862650 @default.
• W2921138927 hasConcept C190248442 @default.
• W2921138927 hasConcept C26760741 @default.
• W2921138927 hasConcept C2779134260 @default.
• W2921138927 hasConcept C2779343474 @default.
• W2921138927 hasConcept C2779517570 @default.
• W2921138927 hasConcept C2779701055 @default.
• W2921138927 hasConcept C2779951463 @default.
• W2921138927 hasConcept C36289849 @default.
• W2921138927 hasConcept C512399662 @default.
• W2921138927 hasConcept C535046627 @default.
• W2921138927 hasConcept C71924100 @default.
• W2921138927 hasConcept C86803240 @default.
• W2921138927 hasConceptScore W2921138927C126322002 @default.
• W2921138927 hasConceptScore W2921138927C142724271 @default.
• W2921138927 hasConceptScore W2921138927C144024400 @default.
• W2921138927 hasConceptScore W2921138927C151730666 @default.
• W2921138927 hasConceptScore W2921138927C15744967 @default.
• W2921138927 hasConceptScore W2921138927C159110408 @default.
• W2921138927 hasConceptScore W2921138927C160798450 @default.
• W2921138927 hasConceptScore W2921138927C169760540 @default.
• W2921138927 hasConceptScore W2921138927C1862650 @default.
• W2921138927 hasConceptScore W2921138927C190248442 @default.
• W2921138927 hasConceptScore W2921138927C26760741 @default.
• W2921138927 hasConceptScore W2921138927C2779134260 @default.
• W2921138927 hasConceptScore W2921138927C2779343474 @default.
• W2921138927 hasConceptScore W2921138927C2779517570 @default.

• next